Glimepiride
Brand name: Glimepiride
Rank #382 of 500 drugs by total cost
$25.3M
Total Cost
1,885,737
Total Claims
$25.3M
Total Cost
41,640
Prescribers
$13
Cost per Claim
401,115
Beneficiaries
4,599,705
30-Day Fills
$606
Avg Cost/Provider
45
Avg Claims/Provider
About Glimepiride
Glimepiride (sold as Glimepiride) was prescribed 1,885,737 times by 41,640 Medicare Part D providers in 2023, costing the program $25.3M. At $13 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 379 | Citalopram Hydrobromide (Citalopram Hbr) | $25.3M | 2,778,255 |
| 380 | Amoxicillin/Potassium Clav (Amoxicillin-Clavulanate Potass) | $25.3M | 2,207,997 |
| 381 | Infliximab (Remicade) | $25.3M | 3,457 |
| 382 | Glimepiride (Glimepiride) | $25.3M | 1,885,737 |
| 383 | Flecainide Acetate (Flecainide Acetate) | $25.1M | 412,334 |
| 384 | Pioglitazone Hcl (Pioglitazone Hcl) | $24.8M | 1,182,614 |
| 385 | Fremanezumab-Vfrm (Ajovy Autoinjector) | $24.7M | 29,389 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology